Ralph Brandenberger
Chief Tech/Sci/R&D Officer at NKARTA, INC.
Net worth: 864 497 $ as of 31/03/2024
Profile
Ralph Brandenberger is currently the Chief Technical Officer at Nkarta, Inc. He previously worked as the Director-Process Sciences at Geron Corp from 2001 to 2012, the Senior Director-Process Development at Neurona Therapeutics, Inc. from 2016 to 2018, and the Head-Technical Operations at Baxalta US, Inc. from 2012 to 2016.
Dr. Brandenberger holds graduate and doctorate degrees from the University of Basel.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NKARTA, INC.
0.11% | 01/03/2024 | 79,972 ( 0.11% ) | 864 497 $ | 31/03/2024 |
Ralph Brandenberger active positions
| Companies | Position | Start |
|---|---|---|
| NKARTA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Former positions of Ralph Brandenberger
| Companies | Position | End |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/03/2018 |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The private company is based in Deerfield, IL. | Corporate Officer/Principal | 01/04/2016 |
| GERON CORPORATION | Corporate Officer/Principal | 01/06/2012 |
Training of Ralph Brandenberger
| University of Basel | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| NKARTA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The private company is based in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Ralph Brandenberger
